Anavex Life Sciences Corp. (AVXL) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Anavex Life Sciences Corp...

    NASDAQ: AVXL · Real-Time Price · USD
    8.66
    0.16 (1.88%)
    At close: Sep 26, 2025, 3:59 PM
    8.66
    0.00%
    After-hours: Sep 26, 2025, 06:47 PM EDT

    Anavex Life Sciences Ratios and Metrics

    Financials in USD. Fiscal year is October - September.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Sep 30, 2024 Sep 30, 2023 Sep 30, 2022 Sep 30, 2021
    PE Ratio
    		 -11.03 -11 -16.54 -33.05
    PEG Ratio
    		 0.83 3.41 -1.12 -1.65
    PS Ratio
    		 n/a n/a n/a n/a
    PB Ratio
    		 3.94 3.68 5.57 8.31
    P/FCF Ratio
    		 -15.39 -18.81 -32.75 -41.24
    P/OCF Ratio
    		 -15.39 -18.81 -32.75 -41.24
    OCF/S Ratio
    		 n/a n/a n/a n/a
    Debt / Equity Ratio
    		 n/a n/a n/a n/a
    Quick Ratio
    		 8.86 12.32 14.95 14.97
    Current Ratio
    		 8.86 12.32 14.95 14.97
    Asset Turnover
    		 n/a n/a n/a n/a
    Interest Coverage
    		 n/a -57.84 -53.84 n/a
    Return on Equity
    		 n/a n/a n/a n/a
    Return on Assets
    		 n/a n/a n/a n/a
    Return on Invested Capital
    		 n/a n/a n/a n/a
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 n/a n/a n/a n/a
    Net Profit Margin
    		 n/a n/a n/a n/a
    Pretax Profit Margin
    		 n/a n/a n/a n/a
    Operating Profit Margin
    		 n/a n/a n/a n/a
    FCF Margin
    		 n/a n/a n/a n/a
    EBITDA Margin
    		 n/a n/a n/a n/a

    Add to Watchlist